Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
9.2
221.03%
Every year
—
76.85%
Every year
—
5 Years
Score9.2
Net Growth221.03%
Net TrendEvery year
Net Income Consistency—
Rev Growth76.85%
Rev TrendEvery year
Revenue Consistency—
ResMed Inc fundamental performance
Between 2021 and 2026, revenue grew from $ 3.19B to $ 5.65B and net income grew from $ 474M to $ 1.52B. Revenue increased in every one of those 5 years; net income in every one.
Across ResMed Inc's full reported history, from 1995 to 2026, revenue grew from $ 23M to $ 5.65B and net income grew from $ 2M to $ 1.52B. Revenue increased in 100% of the years measured; net income in 81%.
ResMed Inc currently holds a 20-year HDB Score of 8.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 226.00 | — |
1 Year2025-08-12 | $ 280.54 | -19.44% |
5 Years2021-08-12 | $ 263.34 | -14.18% |
10 Years2016-08-12 | $ 62.92 | 259.17% |
20 Years2006-08-11 | $ 18.39 | 12x |
30 Years1996-08-12 | $ 0.85 | 265x |
All Time1995-06-02 | $ 0.56 | 406x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1995-06-02 |
|---|---|---|---|---|---|---|---|
| Price | $ 226.00 | $ 280.54 | $ 263.34 | $ 62.92 | $ 18.39 | $ 0.85 | $ 0.56 |
| Return | — | -19.44% | -14.18% | 259.17% | 12x | 265x | 406x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 5.65B | $ 1.52B | $ 1.46B |
| 2025 | $ 5.14B | $ 1.40B | $ 1.20B |
| 2024 | $ 4.68B | $ 1.02B | $ 238M |
| 2023 | $ 4.22B | $ 897M | $ 227M |
| 2022 | $ 3.57B | $ 779M | $ 273M |
| 2021 | $ 3.19B | $ 474M | $ 295M |
| 2020 | $ 2.95B | $ 621M | $ 463M |
| 2019 | $ 2.60B | $ 404M | $ 147M |
| 2018 | $ 2.34B | $ 315M | $ 188M |
| 2017 | $ 2.06B | $ 342M | $ 821M |
| 2016 | $ 1.83B | $ 352M | $ 731M |
| 2015 | $ 1.67B | $ 352M | $ 717M |
| 2014 | $ 1.55B | $ 345M | $ 905M |
| 2013 | $ 1.51B | $ 307M | $ 876M |
| 2012 | $ 1.36B | $ 254M | $ 809M |
| 2011 | $ 1.24B | $ 226M | $ 735M |
| 2010 | $ 1.09B | $ 190M | $ 488M |
| 2009 | $ 920M | $ 146M | $ 415M |
| 2008 | $ 835M | $ 110M | $ 321M |
| 2007 | $ 716M | $ 66M | $ 277M |
| 2006 | $ 606M | $ 88M | $ 219M |
| 2005 | $ 425M | $ 64M | $ 142M |
| 2004 | $ 339M | $ 57M | $ 140M |
| 2003 | $ 273M | $ 45M | $ 121M |
| 2002 | $ 204M | $ 37M | $ 92M |
| 2001 | $ 155M | $ 11M | $ 102M |
| 2000 | $ 115M | $ 22M | $ 21M |
| 1999 | $ 88M | $ 16M | $ 16M |
| 1998 | $ 66M | $ 10M | $ 15M |
| 1997 | $ 49M | $ 7M | $ 9M |
| 1996 | $ 34M | $ 4M | $ 5M |
| IPO1995 | $ 23M | $ 2M | $ 3M |
Explore beyond RMD
You're looking at ResMed Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
